These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6452910)

  • 1. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
    London ED; Yamamura HI; Bird ED; Coyle JT
    Biol Psychiatry; 1981 Feb; 16(2):155-62. PubMed ID: 6452910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
    Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
    Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease.
    Wagster MV; Hedreen JC; Peyser CE; Folstein SE; Ross CA
    Exp Neurol; 1994 May; 127(1):70-5. PubMed ID: 7515353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
    Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of 3H-kainic acid binding to brain membranes in rats and frogs].
    Zharkovskiĭ AM; Zharkovskaia TA
    Biull Eksp Biol Med; 1985 May; 99(5):586-9. PubMed ID: 4005415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kainic acid binding in human caudate nucleus: effect of Huntington's disease.
    Henke H
    Neurosci Lett; 1979 Oct; 14(2-3):247-51. PubMed ID: 161000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease and its animal model: alterations in kainic acid binding.
    Beaumont K; Maurin Y; Reisine TD; Fields JZ; Spokes E; Bird ED; Yamamura HI
    Life Sci; 1979 Feb; 24(9):809-16. PubMed ID: 156298
    [No Abstract]   [Full Text] [Related]  

  • 12. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
    Mjörndal T; Winblad B
    Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
    Cross AJ; Slater P; Reynolds GP
    Neurosci Lett; 1986 Jun; 67(2):198-202. PubMed ID: 2873534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of [3H]kainic acid to receptor sites in rat brain.
    London ED; Coyle JT
    Mol Pharmacol; 1979 May; 15(3):492-505. PubMed ID: 492142
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of kainic acid injection and cortical lesion on ornithine and aspartate aminotransferases in rat striatum.
    Wong PT; McGeer EG; McGeer PL
    J Neurosci Res; 1982; 8(4):643-50. PubMed ID: 6131142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.
    Berrendero F; Sepe N; Ramos JA; Di Marzo V; Fernández-Ruiz JJ
    Synapse; 1999 Sep; 33(3):181-91. PubMed ID: 10420166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
    Seeman P; Guan HC; Nobrega J; Jiwa D; Markstein R; Balk JH; Picetti R; Borrelli E; Van Tol HH
    Synapse; 1997 Feb; 25(2):137-46. PubMed ID: 9021894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of unique kainic acid-like molecules in urine, serum, and CSF from Huntington's disease patients.
    Beutler BA; Noronha AB; Poon MM; Arnason BG
    J Neurol Sci; 1981 Sep; 51(3):355-60. PubMed ID: 6115893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.